Give her effective vaginal atrophy treatment with BlisselⓇ

BlisselⓇ is well-tolerated and effective in the treatment of postmenopausal vaginal atrophy.1

BlisselⓇ allows you to treat vaginal atrophy whilst limiting systemic exposure to estrogens

Low dose estriol formulations, such as BlisselⓇ, have significantly lower systemic absorption than higher dose medications.2

BlisselⓇ is well-tolerated and effective in the treatment of postmenopausal vaginal atrophy.1

BlisselⓇ allows you to treat vaginal atrophy whilst limiting systemic exposure to estrogens

Low dose estriol formulations, such as BlisselⓇ, have significantly lower systemic absorption than higher dose medications.2

BlisselⓇ works quickly

BlisselⓇ is effective for treating vaginal dryness

which improves or completely resolves in over 88% of women.1*

*vs placebo, P=0.001; relative risk [RR], 1.32; CI, 1.08-1.62.

BlisselⓇ significantly improves changes due to vaginal atrophy1:

Administration

BlisselⓇ can be administered by the patient using the included applicator3

Ensuring that the process is comfortable and mess-free.

View How To Use Guide

Precautions3

  • For the treatment of postmenopausal symptoms, local estrogen therapy should only be initiated for symptoms that adversely affect quality of life.
  • In all cases, a careful appraisal of the risks and benefits should be undertaken at least annually and HRT should only be continued as long as the benefit outweighs the risk.
  • BlisselⓇ 50 micrograms/g vaginal gel must not be combined with estrogen preparations for systemic treatment, as there are no studies of safety and risks with estrogen concentrations attained in combination treatment.
  • Intravaginal applicator may cause minor local trauma, especially in women with serious vaginal atrophy.

For full information see the summary of product characteristics.3

Common (>1/100 to <1/10) and uncommon (>1/1000 to <1/100) undesirable effects3

Release her confidence from within.

To book a visit from a Consilient Healthcare BlisselⓇ trained healthcare manager, please click here to complete our DATA compliant form:

Contact Us

Vaginal

Atrophy

How BlisselⓇ

Works

Dosing

Ultra low dose estriol vaginal gel1

Prescribing and Adverse event reporting information for BlisselⓇ can be found here.

 Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Consilient Health (UK) Ltd, No. 1 Church Road, Richmond upon Thames, Surrey TW9 2QE UK or drugsafety@consilienthealth.com 

  1. Cano A, et al. Menopause. 2012;19(10):1130-9. 2. Delgado JL, et al. Climacteric. 2016;19(2):172-80. 3. Blissel 50 micrograms/g vaginal gel. Summary of product characteristics.

Date or preparation: Jan 2024 | UK-BLS-43d(2)